Tactile Medical to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference
December 07 2017 - 11:00AM
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD),
a medical technology company focused on developing medical devices
for the treatment of chronic diseases at home, today announced that
management will participate in the Guggenheim Securities 5th Annual
Boston Healthcare Conference at the InterContinental Hotel in
Boston, MA. Management will attend on Wednesday, December 13 and
participate in investor meetings. There will be no formal
presentation to investors.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home
therapy devices that treat chronic swelling conditions such as
lymphedema and chronic venous insufficiency. Our mission is to help
people suffering from chronic diseases live better and care for
themselves at home. Our unique offering includes advanced,
clinically proven pneumatic compression devices, as well as
continuity of care services provided by a national network of
product specialists and trainers, reimbursement experts, patient
advocates, and clinical staff. This combination of products and
services ensures that tens of thousands of patients annually
receive the at-home treatment necessary to better manage their
chronic conditions. Tactile Medical takes pride in the fact that
our solutions help increase clinical efficacy, reduce overall
healthcare costs and improve the quality of life for patients with
chronic conditions.
Investor Inquiries:
Mike Piccinino, CFA
Managing Director
Westwicke Partners
443-213-0500
investorrelations@tactilemedical.com
Tactile Systems Technology (NASDAQ:TCMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tactile Systems Technology (NASDAQ:TCMD)
Historical Stock Chart
From Sep 2023 to Sep 2024